(Q36204209)

12 August 2017

1 reference

title

Langerhans cell histiocytosis: current insights in a molecular age with emphasis on clinical oral and maxillofacial pathology practice (English)

1 reference

Langerhans cell histiocytosis specific to childhood

12 August 2017

main subject

1 reference

John Hicks

1

1 reference

12 August 2017

Catherine M Flaitz

series ordinal

2

1 reference

12 August 2017

language of work or name

1 reference

1 August 2005

1 reference

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

12 August 2017

published in

1 reference

12 August 2017

volume

100

1 reference

12 August 2017

issue

2 Suppl

1 reference

12 August 2017

page(s)

S42-66

1 reference

The Langerhans cell histiocytosis X files revealed

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans' cell histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Eosinophilic granuloma of bone; case report of eosinophilic granuloma of mouth (jaws, gums, and palate) with simultaneous fistula in ano

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

The histiocytoses: the fall of the Tower of Babel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans cell histiocytosis and other disorders of monocyte-histiocyte lineage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Presence of circulating abnormal CD34+ progenitors in adult Langerhans cell histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

7 January 2021

The other histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Increased Blood Myeloid Dendritic Cells and Dendritic Cell-Poietins in Langerhans Cell Histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans cell histiocytosis research. Past, present, and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans cell histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

The epidemiology of Langerhans cell histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Paediatric manifestations of Langerhans cell histiocytosis: a review of the clinical and radiological findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans cell histiocytosis in adults: more questions than answers?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans'-cell histiocytosis in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Congenital Langerhans cell histiocytosis: the self-healing variety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Histiocytosis X: a review of 114 cases with oral involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Clinical and radiographic features of eosinophilic granuloma in the jaws: review of 41 lesions treated by surgery and low-dose radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans' cell histiocytosis of the jaw bones. Report of 11 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans' cell histiocytosis restricted to the oral mucosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Maxillofacial manifestations of Langerhans cell histiocytosis: a clinical and therapeutic analysis of 10 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Histiocytosis X. An analysis of 50 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Eosinophilic granuloma: resolution of maxillofacial bony lesions following minimal intervention. Report of three cases and a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Oral Langerhans cell histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Head and neck Langerhans cell histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Fascin and the differential diagnosis of childhood histiocytic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where Langerin accumulates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerin/CD207 Sheds Light on Formation of Birbeck Granules and Their Possible Function in Langerhans Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Juvenile xanthogranuloma of the oral cavity in children: a clinicopathologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Juvenile xanthogranuloma as a sequel to Langerhans cell histiocytosis: a report of three cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans cell histiocytosis and juvenile xanthogranuloma. Two case reports

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans cell histiocytosis: a pathologic combination of oncogenesis and immune dysregulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

An hypothesis Langerhans cell histiocytosis: the failure of the immune system to switch from an innate to an adaptive mode

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Is Langerhans cell histiocytosis a myeloid dendritic stem cell disorder related to myelodysplastic disorders?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans-cell histiocytosis 'insight into DC biology'.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Interleukin-3 in cooperation with transforming growth factor beta induces granulocyte macrophage colony stimulating factor independent differentiation of human CD34+ hematopoietic progenitor cells into dendritic cells with features of Langerhans cel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Expression profiling using human tissues in combination with RNA amplification and microarray analysis: assessment of Langerhans cell histiocytosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

p53 expression in biopsies from children with Langerhans cell histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Serum levels of interleukin-1 receptor antagonist and tumor necrosis factor-alpha are elevated in children with Langerhans cell histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans' cell histiocytosis is caused by dysregulation of the E-cadherin-beta-catenin cascade: a hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Nosology and pathology of Langerhans cell histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Expression of cell cycle-related gene products in Langerhans cell histiocytosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

An update on clonality, cytokines, and viral etiology in Langerhans cell histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans cell histiocytosis: Lack of a viral etiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Detection of molecular cytogenetic aberrations in langerhans cell histiocytosis of bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Familial clustering of Langerhans cell histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Langerhans cell histiocytosis patients have HLA Cw7 and DR4 types associated with specific clinical presentations and no increased frequency in polymorphisms of the tumor necrosis factor alpha promoter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Concurrent Langerhans cell histiocytosis and myelodysplasia in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Cytogenetic abnormalities in PHA-stimulated lymphocytes from patients with Langerhans cell histocytosis. AIEOP-Istiocitosi Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Cytogenetic abnormalities in Langerhans cell histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Genotypic analysis of pulmonary Langerhans cell histiocytosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Current therapy for Langerhans cell histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Controversies and new approaches to treatment of Langerhans cell histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

A randomized trial of treatment for multisystem Langerhans' cell histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Successful treatment of cutaneous langerhans cell histiocytosis with thalidomide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Retinoic acid therapy in "degenerative-like" neuro-langerhans cell histiocytosis: a prospective pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Immunosuppressive treatment for chemotherapy-resistant multisystem Langerhans cell histiocytosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Interferon-alpha therapy in children with malignant diseases: clinical experience in twenty-four patients treated in a single pediatric oncology unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

Multifocal eosinophilic granuloma of the jaw: long-term follow-up of a novel intraosseous corticoid treatment for recalcitrant lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.06.016

10.1016/J.TRIPLEO.2005.06.016

7 January 2021

Identifiers

DOI

1 reference

12 August 2017

1 reference